跳至主要内容
临床试验/DRKS00034175
DRKS00034175招募中不适用

Analyses of the microbiome and mircobial metabolites in the prevention and treatment of Graft-versus-Host disease - M&M-A

Klinikum rechts der Isar0 个研究点目标入组 130 人开始时间: 2024年7月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • planned allogenic stem cell transplantation

排除标准

  • CED, Hemoglobin <7g/dl, Thrombocytes <50/nl, Quick <50%

研究者

发起方
Klinikum rechts der Isar

相似试验

尚未招募
不适用
Analysis of the gut microbial metabolites and microbiome in the blood, urine, feces from healthy individualsAllergic diseases, metabolic related diseases
JPRN-UMIN000039223Department of Pharmacology, Keio University School of Medicine40
已完成
不适用
Analysis of intestinal metabolite and microbiota by endoscopic retrograde bowel insertion methodHealty adult
JPRN-UMIN000018128Hirosaki University Graduate School of Medicine20
暂停
不适用
ew technologies in diagnosing and monitoring lung diseasePulmonary diseases (COPD, lung cancer, asthma and others)Respiratory
ISRCTN16657101Hywel Dda University Health Board2,000
尚未招募
不适用
MICROBIAL COMMUNITY AND METABOLITE IN GUT MICROBIOME OF LONG-TERM VEGETARIAN AND BIOMARKER ASSOCIATED TO HEALTH CONDITIONS1. body mass indexBMI is lower than 25. 2. Healthy (Do not have chronic diseases related to the gastrointestinal tract and Metabolic Syndrome e.g., obesity, diabetes (types 1 and 2), high blood pressure, fatty liver disease, cardiovascular disease, Crohn&#039s disease, Ulcerative colitis, Bacterial overgrowth syndrome, Celiac disease and Irritable Bowel Syndrome).3. People who do not have Haemophilia or Hemorrhagic disease, liver disease, heart disease, or people who must not receive medicine which affects on blood clotting such as warfarin, rivaroxaban Dabigatran, Apixaban, Edoxaban and Heparin.Vegan health, Gut Microbiota, Metabolite
TCTR20240619003Faculty of Science, Chulalongkorn University68
已完成
不适用
Study of the involvement of the gut microbiota in the pathophysiology and treatment effect of patients with unresectable hepatocellular carcinoma.Hepatocellular carcinoma
JPRN-UMIN000042709Kurume university60